Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?
Schennach R, Riesbeck M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Jäger M, Wölwer W, Gaebel W, Möller HJ, Riedel M. Schennach R, et al. Among authors: klosterkotter j. Acta Psychiatr Scand. 2013 Jun;127(6):474-81. doi: 10.1111/acps.12006. Epub 2012 Sep 8. Acta Psychiatr Scand. 2013. PMID: 22957829 Clinical Trial.
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W. Möller HJ, et al. Among authors: klosterkotter j. Int J Neuropsychopharmacol. 2008 Nov;11(7):985-97. doi: 10.1017/S1461145708008791. Epub 2008 May 9. Int J Neuropsychopharmacol. 2008. PMID: 18466670 Free article. Clinical Trial.
Internal capsule size associated with outcome in first-episode schizophrenia.
Wobrock T, Gruber O, Schneider-Axmann T, Wölwer W, Gaebel W, Riesbeck M, Maier W, Klosterkötter J, Schneider F, Buchkremer G, Möller HJ, Schmitt A, Bender S, Schlösser R, Falkai P. Wobrock T, et al. Among authors: klosterkotter j. Eur Arch Psychiatry Clin Neurosci. 2009 Aug;259(5):278-83. doi: 10.1007/s00406-008-0867-y. Epub 2009 Feb 17. Eur Arch Psychiatry Clin Neurosci. 2009. PMID: 19224108 Free PMC article.
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?
Schennach-Wolff R, Jäger M, Mayr A, Meyer S, Kühn KU, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Gaebel W, Seemüller F, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: klosterkotter j. Eur Neuropsychopharmacol. 2011 May;21(5):370-8. doi: 10.1016/j.euroneuro.2010.10.003. Epub 2011 Jan 20. Eur Neuropsychopharmacol. 2011. PMID: 21255982 Clinical Trial.
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R. Riedel M, et al. Among authors: klosterkotter j. World J Biol Psychiatry. 2012 Jan;13(1):30-8. doi: 10.3109/15622975.2011.552633. Epub 2011 May 13. World J Biol Psychiatry. 2012. PMID: 21568628 Clinical Trial.
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
Schennach-Wolff R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: klosterkotter j. J Psychiatr Res. 2011 Dec;45(12):1639-47. doi: 10.1016/j.jpsychires.2011.07.014. Epub 2011 Aug 20. J Psychiatr Res. 2011. PMID: 21862035
Response trajectories in "real-world" naturalistically treated schizophrenia patients.
Schennach R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Musil R, Möller HJ, Riedel M. Schennach R, et al. Among authors: klosterkotter j. Schizophr Res. 2012 Aug;139(1-3):218-24. doi: 10.1016/j.schres.2012.05.004. Epub 2012 Jun 2. Schizophr Res. 2012. PMID: 22658528
Akathisia and suicidal ideation in first-episode schizophrenia.
Seemüller F, Schennach R, Mayr A, Musil R, Jäger M, Maier W, Klingenberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Ohmann C, Lewitzka U, Gaebel W, Möller HJ, Riedel M; German Study Group on First-Episode Schizophrenia. Seemüller F, et al. Among authors: klosterkotter j. J Clin Psychopharmacol. 2012 Oct;32(5):694-8. doi: 10.1097/JCP.0b013e3182677958. J Clin Psychopharmacol. 2012. PMID: 22926606 Clinical Trial.
Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia.
Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Heuser I, Maier W, Klosterkötter J, Falkai P, Schlösser R, Schmitt A, Riedel M, Klingberg S, Köpcke W, Ohmann C, Möller HJ. Gaebel W, et al. Among authors: klosterkotter j. Schizophr Res. 2014 Feb;152(2-3):478-86. doi: 10.1016/j.schres.2013.04.012. Epub 2013 May 1. Schizophr Res. 2014. PMID: 23643327
311 results